
    
      The REPRISE II clinical study is a prospective, single-arm, multicenter study designed to
      evaluate the safety and performance of the Lotus Valve System for TAVR in symptomatic
      subjects who have severe calcific aortic valve stenosis and who are at high risk for surgical
      aortic valve replacement (SAVR).
    
  